Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy
Mutations in genes encoding chromatin regulators are early events contributing to developing asymptomatic clonal hematopoiesis of indeterminate potential and its frequent progression to myeloid diseases with increasing severity. We focus on the subset of myeloid diseases encompassing myelodysplastic...
Main Authors: | Michael Maher, Jeannine Diesch, Marguerite-Marie Le Pannérer, Marcus Buschbeck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1746 |
Similar Items
-
Acute Myeloid Leukemia: Aging and Epigenetics
by: Polina Zjablovskaja, et al.
Published: (2019-12-01) -
Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia
by: Brigitte Schlegelberger, et al.
Published: (2013-07-01) -
Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
by: Alexander J. Ambinder, et al.
Published: (2022-10-01) -
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
by: Kelly S. Chien, et al.
Published: (2024-03-01) -
Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
by: Samantha L. Goldman, et al.
Published: (2019-03-01)